Skip to main content
. Author manuscript; available in PMC: 2009 Jun 25.
Published in final edited form as: Inf Sci (N Y). 2007 Sep 15;177(18):3749–3763. doi: 10.1016/j.ins.2007.03.011

Table 2.

A part of an expert’s ranking of the three regimens.

Potency Adherence Adverse events Future drug options 1st choice 2nd choice 3rd choice
High Easy Medium High 3 1 2
High Easy Medium Medium 1 2 3
High Moderate Very Low Medium 1 3 2